Profile
Sarah J.
Alexander served as an Independent Director at NewLink Genetics Corp.
from 2012 to 2012.
Prior to that, she obtained a doctorate degree from Emory University.
Former positions of Sarah J. Alexander
Companies | Position | End |
---|---|---|
LUMOS PHARMA, INC. | Director/Board Member | 2012-11-01 |
Training of Sarah J. Alexander
Emory University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
NewLink Genetics Corp.
NewLink Genetics Corp. Pharmaceuticals: MajorHealth Technology NewLink Genetics Corp. is a late-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of novel immunotherapeutic products to improve cancer treatment options for patients and physicians. The firm's portfolio includes biologic and small molecule immunotherapy product candidates intended to treat a range of oncology indications. It products include HyperAcute Pancreas, HyperAcute Lung, HyperAcute Melanoma, HyperAcute Imunotherapies, NLG8189, and IDO Pathway Inhibitors. The company was founded by Charles J. Link and Nicholas N. Vahanian on June 4, 1999 and is headquartered in Ames, IA. | Health Technology |
- Stock Market
- Insiders
- Sarah J. Alexander